Position in EYPT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$8,724,104
-$1,828,391 QoQ
Shares Held
676,812
+17.2% QoQ
Ownership
0.807%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 98.34902454448206.ToString("F0")%
Shared 1.6509754555179283.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. EYPT ranks #107 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in EYPT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,724,104 | 676,812 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $10,552,495 | 577,586 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $7,177,713 | 504,053 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $4,851,917 | 515,613 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $3,413,941 | 629,879 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,791,518 | 643,157 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,769,545 | 471,783 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,783,982 | 319,998 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,660,389 | 322,225 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,537,640 | 239,621 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,691,602 | 211,715 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,829,644 | 210,304 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $608,382 | 206,933 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $713,314 | 203,804 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,656,472 | 209,415 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,684,565 | 214,049 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,537,464 | 208,845 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,276,970 | 186,027 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,009,267 | 192,828 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $627,348 | 69,783 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $462,493 | 45,521 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $98,206 | 14,925 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||